Cross-Reactivity of Non-Neutralizing Antibodies to Dengue and Zika Viruses: Implications for Vaccination
<p>Dengue is the leading vector-borne viral disease of humans and poses a major international public health concern in tropical and subtropical regions in which it is endemic. Cross-reactivity among the different serotypes of dengue virus promotes antibody-dependent enhancement of secondary in...
Saved in:
Main Author: | Andrew W Taylor-Robinson (Author) |
---|---|
Format: | Book |
Published: |
Archives of Preventive Medicine - Peertechz Publications,
2017-02-18.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can Zika virus antibodies cross-protect against dengue virus?
by: Kevin K Ariën, et al.
Published: (2018) -
Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
by: Mei-Liang Huang, et al.
Published: (2013) -
Can Zika virus antibodies cross-protect against dengue virus? - Authors' reply
by: Guilherme S Ribeiro, et al.
Published: (2018) -
Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
by: Priscila M S Castanha, et al.
Published: (2019) -
Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.
by: Chih-Yun Lai, et al.
Published: (2013)